10/20/2021, 1:34 PM (Source: TeleTrader)
more TeleTrader news

Abbott's Q3 revenue rises by 23.4% YoY to $10B

Abbott Laboratories announced on Wednesday its revenue in the third quarter of 2021 came in at $10.9 billion, which is an increase of 23.4% in comparison to the same period the year before, beating expectations. The company's diluted earnings per share (EPS) went up by 42.9% on an annual level to $1.17 per share.

"We achieved another quarter of strong growth overall and across all four of our major business areas," Abbott President and Chief Executive Officer (CEO) Robert B. Ford commented. "We're particularly pleased with the continued advancements of our new product pipeline, including several recent launches in large, high-growth markets."

Following the release of the report, the company's shares rose by 2.63% in premarket trading.

Baha Breaking the News (BBN) / JR